Skip to content

Public FDA record

Z-1041-2022: Philips Hemodynamic Application, Model Number 722463, Software Version Number: R1.2.2 and R1.2.3. For vi

Recall record Z-1041-2022 for Philips North America Llc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1041-2022
Company in FDA record
Philips North America Llc
FDA record creation date
May 6, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

When a Neonatal patient is admitted, the Non-Invasive Blood Pressure is not set to Neonatal mode on the Philips Xperflex Cardio FC2010 patient monitor. If the NIBP is not set to Neonatal, the cuff inflation pressure applied will be higher than 150 mmHg and the deflation pressure will be higher than 5 mmHg. An applied cuff inflation pressure higher than 150mmHg or a deflation pressure higher than 5 could lead to bruising, mmHg nerve damage or bone deformity for a neonate.

Source facts

Action
An URGENT Medical Device Correction notification letter dated 2/18/22 was sent to customers. Actions that should be taken by the customer/ user in order to prevent risks for patients. Do not use the Non-Invasive Blood Pressure for Neonatal Patients until Philips has installed a new software revision that will solve this problem. Place this Urgent Medical Device Correction letter with the documentation of the Philips Hemodynamic Application until Philips implements the new software revision. Return the attached reply form to Philips to confirm that the users of the system have reviewed and understood this Urgent Medical Device Correction letter. Actions planned by Philips to correct the problem. To correct this problem, Philips will install a new software revision to update the Hemodynamic Application to revision Rl.3. This new revision will be available as of March 2022. Philips will be contacting customers with an affected Philips Hemodynamic Application to install the new software revision. Please be assured that maintaining a high level of safety and quality is our highest priority. If you need any further information, please contact your local Philips Cardiology representative.
Initiated
2022-02-22
Root cause
Under Investigation by firm
Terminated
2024-11-06
Distribution
Devices were distributed to the following US states: FL, ID, NJ, OK, SC and TX. Devices were distributed to the following foreign countries: France, Germany, India, Mexico, Netherlands, New Zealand, Norway, Poland, South Africa, and Switzerland.
Recall number
Z-1041-2022
Recall status
Terminated
CDRH record ID
192768
FDA record created
2022-05-06
Recall event number
89878

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗